April 2 (Reuters) -
* INITIATES PHASE II CLINICAL TRIAL OF APN01FOR TREATMENT OF COVID-19
* REGULATORY APPROVALS OBTAINED FOR TREATMENT OF 200 COVID-19 PATIENTS IN AUSTRIA, GERMANY AND DENMARK Source text for Eikon: (Gdansk Newsroom)
Our Standards: The Thomson Reuters Trust Principles.